Teva completes $40 billion acquisition of Actavis Generics | Pharmafile
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Intas Pharmaceuticals completes deal to acquire Actavis UK & Ireland generics businesses from Teva - Pharmacy In Focus
Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times
Teva Forecasts Growth After Expected Actavis Deal Closes | Stock News & Stock Market Analysis - IBD
Teva says Actavis Closing on Track | CHEManager
Actavis Generics acquired by Teva Pharmaceutical Industries - MaltaToday.com.mt
Actavis Generics Acquisition Drives Teva Pharmaceutical Industries Ltd. First-Quarter Sales Higher | The Motley Fool
Teva receives US clearance for Actavis acquisition - Globes
Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
Teva Cuts 14,000 Jobs: The Inside Story of How Israeli Drugmaker Wiped Out $57 Billion in Two Years - Business - Haaretz.com
Teva completes $40.5B Actavis deal, agrees to buy Anda for $500M - Philadelphia Business Journal
Teva Cuts 14,000 Jobs: The Inside Story of How Israeli Drugmaker Wiped Out $57 Billion in Two Years - Business - Haaretz.com
Teva, Actavis y Taro se enfrentan a una demanda colectiva por fijación de precios - Top Class Actions
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva Completes Acquisition of Actavis Generics
Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
Teva unclear on which generics affected by Actavis buyout :: C+D
Actavis bought by Israeli pharmaceutical company - MaltaProfile.info
eKapija | Teva acquires Actavis for USD 33.43 billion and 100 million shares – Modern pharmaceutical drugs and therapies more available to clients in Serbia
TEVA Pharmaceutical (3/10) - Rankia
Teva Pharmaceuticals - Wikipedia
Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times
Teva sells Actavis UK, Ireland assets for £603m - Globes
Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
Why Teva Paid $40.5 Billion for Allergan's Generic Business - Knowledge at Wharton
